Meanwhile, cell functional experiments showed that the enhanced migratory and invasive abilities induced by sh-DHRS9 treatment in colon cancer cells were inhibited after overexpressing FXR simultaneously (Figures 4(d) and 4(e)). The gene discussed is NR1H4; the disease is colonic neoplasm.